-

SHAREHOLDER ALERT: Robbins LLP Reminds Investors that Live Ventures Inc. (LIVE) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Live Ventures Inc. (NASDAQ: LIVE) securities between December 28, 2016 and August 3, 2021, for violations of the Securities Exchange Act of 1934. Live Ventures is a holding company. Until 2015, Live Ventures focused on providing online marketing solutions for small and medium business. Thereafter, the Company shifted to acquiring purportedly profitable businesses in various industries that have demonstrated a strong history of earnings power.

If you suffered a loss due to Live Ventures Inc.'s misconduct, click here.

Live Ventures Inc. (LIVE) Made Misleading Statements Regarding its Business, Operations, and Prospects

According to the complaint, during the class period, defendants made materially false and misleading statements and failed to disclose a variety of facts to investors. Specifically, Live Ventures failed to disclose that its earnings per share for FY 2016 was only $6.33 per share; that the Company used an artificially low share count to boost the earnings per share by 40%; and that Live Ventures had overstated pre-tax income for fiscal 2016 by 20% by including $915,500 of "other income" related to certain amendments that were not negotiated until after the close of the fiscal year. Additionally, Live Venture made numerous false statements regarding its acquisition of ApplianceSmart and the manner in which it recognized income therefrom did not conform to generally accepted accounting principles. Finally, the Company failed to disclose that its CEO received more compensation than was disclosed to investors.

On August 3, 2021, the U.S. Securities and Exchange Commission (SEC) filed a complaint against Live Ventures, its Chief Executive Officer, and its Chief Financial Officer alleging "multiple financial, disclosure, and reporting violations related to inflated income and earnings per share, stock promotion and secret trading, and undisclosed executive compensation." Specifically, the SEC alleged that Live Ventures had recorded income from a backdated contract, which increased pre-tax income for fiscal 2016 by 20%, and understated its outstanding share count, which overstated earnings per share by 40%. On this news, the Company's share price fell $29.08, or 46%, to close at $33.50 per share on August 4, 2021. The stock continued to decline, and fell another 23% over the next four consecutive trading sessions to close at $25.76 per share on August 10, 2021.

If you purchased shares of Live Ventures Inc. (LIVE) between December 28, 2016 and August 3, 2021, you have until September 24, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Live Ventures Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:LIVE

Release Summary
Live Ventures Inc. (LIVE) Made Misleading Statements Regarding its Business, Operations, and Prospects
Release Versions
$Cashtags

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, submi...

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...
Back to Newsroom